Breaking Therapeutic Inertia in Type 2 Diabetes: Active Detection of In-Patient Cases Allows Improvement of Metabolic Control at Midterm
Type 2 diabetes (T2D) exists in 25–40% of hospitalized patients. Therapeutic inertia is the delay in the intensification of a treatment and it is frequent in T2D. The objectives of this study were to detect patients admitted to surgical wards with hyperglycaemia (HH; fasting glycaemia > 140 mg/dL...
Saved in:
| Main Authors: | Anna M. Lucas Martín, Elena Guanyabens, R. Zavala-Arauco, Joaquín Chamorro, Maria Luisa Granada, Didac Mauricio, Manuel Puig-Domingo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2015/381415 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Most Consequential Midterms in History
by: Jiffer Bourguignon
Published: (2022-10-01) -
Midterm Outcomes With the Nellix Endograft Alone or With Chimneys
by: Salomé Kuntz, et al.
Published: (2024-01-01) -
Polypharmacy, therapeutic inertia, and adherence of heart recipients to drug therapy
by: I. I. Muminov, et al.
Published: (2025-01-01) -
Early and Midterm Outcomes of Percutaneous Arteriovenous Fistula Creation
by: Ahmed Kamel Abdel Aal, et al.
Published: (2025-01-01) -
Midterm Outcomes and Surgical Approaches for Osteochondral Lesions of the Talus
by: Christoph Biehl PD, et al.
Published: (2025-04-01)